feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Coca-Cola faces plastic criticism

trending

Texans upset Kansas City Chiefs

trending

LeBron James faces 76ers

trending

Caitlin Clark declined overseas offer

trending

Taylor Swift at Texans game?

trending

Guilford County schools early dismissal

trending

Golden Globes nominations unveiled December

trending

Walmart Lexington bomb threat

trending

IBM nears Confluent acquisition

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Shingles Shot Boosts Brain Health, Study Finds

Shingles Shot Boosts Brain Health, Study Finds

3 Dec

•

Summary

  • Shingles vaccine linked to reduced early memory and thinking problems.
  • Vaccinated dementia patients showed a lower risk of dying from disease.
  • Research suggests potential therapeutic benefits for existing dementia.

New research published in the journal Cell reveals that the shingles vaccine may significantly contribute to long-term brain health. Analysis of over 282,500 adults in Wales indicates that those who received the vaccine were less prone to early-stage memory and cognitive decline. This groundbreaking study even observed that among individuals with existing dementia, vaccination correlated with a decreased risk of death. Researchers are exploring two primary mechanisms: reduced nervous system inflammation and a strengthened overall immune system, both of which are known to play roles in dementia development. Experts consider these findings promising, suggesting a potential dual role for the shingles vaccine in both prevention and treatment of cognitive decline. While further studies are needed for definitive proof, the evidence provides a strong foundation for future research into dementia risk reduction strategies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Stanford University researchers found that adults vaccinated for shingles were less likely to develop early memory and thinking problems, suggesting a preventative role.
Yes, in a study of Welsh adults, those with dementia who received the shingles vaccine showed a lower risk of dying from the disease.
Scientists suggest the vaccine might reduce nervous system inflammation or bolster the immune system's overall strength, both of which are linked to dementia risk.

Read more news on

Healthside-arrow

You may also like

Tattoo Ink Invades Lymph Nodes, Alters Immunity

1 day ago • 8 reads

article image

Vaccine Hesitancy Threatens PA School Safety

5 Dec • 18 reads

article image

FDA Vaccine Review: Child Death Claims Questioned

4 Dec • 19 reads

article image

HPV Vaccine: 80% Cervical Cancer Risk Drop

3 Dec • 105 reads

article image

Vaccine Panel May Delay Infant Hepatitis B Shot

2 Dec • 34 reads

article image